P2X7 Receptor at the Crossroads of T Cell Fate

The P2X7 receptor is a ligand-gated, cation-selective channel whose main physiological ligand is ATP. P2X7 receptor activation may also be triggered by ARTC2.2-dependent ADP ribosylation in the presence of extracellular NAD. Upon activation, this receptor induces several responses, including the influx of calcium and sodium ions, phosphatidylserine externalization, the formation of a non-selective membrane pore, and ultimately cell death. P2X7 receptor activation depends on the availability of extracellular nucleotides, whose concentrations are regulated by the action of extracellular nucleotidases such as CD39 and CD38. The P2X7 receptor has been extensively studied in the context of the immune response, and it has been reported to be involved in inflammasome activation, cytokine production, and the migration of different innate immune cells in response to ATP. In adaptive immune responses, the P2X7 receptor has been linked to T cell activation, differentiation, and apoptosis induction. In this review, we will discuss the evidence of the role of the P2X7 receptor on T cell differentiation and in the control of T cell responses in inflammatory conditions.

[1]  C. Hess,et al.  Long-lived T follicular helper cells retain plasticity and help sustain humoral immunity , 2020, Science Immunology.

[2]  B. Evavold,et al.  CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence. , 2020, Cell Reports.

[3]  S. Jameson,et al.  Self-Regulation of Memory CD8 T Cell Metabolism through Extracellular ATP Signaling. , 2019, Immunometabolism.

[4]  H. Chen,et al.  Extracellular ATP activates P2X7R-NF-κB (p65) pathway to promote the maturation of bone marrow-derived dendritic cells of mice. , 2019, Cytokine.

[5]  C. Marquette,et al.  Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality? , 2019, Biomedical journal.

[6]  D. Masopust,et al.  Tissue-Resident T Cells and Other Resident Leukocytes. , 2019, Annual review of immunology.

[7]  M. Idzko,et al.  P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus , 2019, The Journal of experimental medicine.

[8]  R. V. van Lier,et al.  TRM maintenance is regulated by tissue damage via P2RX7 , 2018, Science Immunology.

[9]  A. Mellouk,et al.  CD8+, but not CD4+ effector/memory T cells, express the CD44highCD45RBhigh phenotype with aging, which displays reduced expression levels of P2X7 receptor and ATP‐induced cellular responses , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  F. Di Virgilio,et al.  Extracellular ATP and P2 purinergic signalling in the tumour microenvironment , 2018, Nature Reviews Cancer.

[11]  E. Hanse,et al.  The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells , 2018, Nature.

[12]  Jiong Yang,et al.  ATP/P2X7‐NLRP3 axis of dendritic cells participates in the regulation of airway inflammation and hyper‐responsiveness in asthma by mediating HMGB1 expression and secretion , 2018, Experimental cell research.

[13]  J. Kanellopoulos,et al.  Variations in Cellular Responses of Mouse T Cells to Adenosine-5′-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage , 2018, Front. Immunol..

[14]  J. Sáez,et al.  ATP promotes the fast migration of dendritic cells through the activity of pannexin 1 channels and P2X7 receptors , 2017, Science Signaling.

[15]  A. Ballabio,et al.  Lysosome signaling controls the migration of dendritic cells , 2017, Science Immunology.

[16]  R. Shaw,et al.  AMPK: guardian of metabolism and mitochondrial homeostasis , 2017, Nature Reviews Molecular Cell Biology.

[17]  T. Kawate,et al.  The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition , 2017, eLife.

[18]  D. Olivieri,et al.  P2X7 receptor drives Th1 cell differentiation and controls the follicular helper T cell population to protect against Plasmodium chabaudi malaria , 2017, PLoS pathogens.

[19]  F. Di Virgilio,et al.  The P2X7 Receptor in Infection and Inflammation , 2017, Immunity.

[20]  Hao Li,et al.  Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis , 2017, Clinical Neurology and Neurosurgery.

[21]  T. Kawate,et al.  Structural basis for subtype-specific inhibition of the P2X7 receptor , 2016, eLife.

[22]  M. Kim,et al.  Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7 , 2016, Mucosal Immunology.

[23]  Zhidan Fan,et al.  Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice , 2016, Scientific Reports.

[24]  F. Quintana,et al.  Purinergic Signaling as a Regulator of Th17 Cell Plasticity , 2016, PloS one.

[25]  L. Fainboim,et al.  ATP-Induced Inflammation Drives Tissue-Resident Th17 Cells in Metabolically Unhealthy Obesity , 2016, The Journal of Immunology.

[26]  J. Linden,et al.  Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.

[27]  M. Bono,et al.  CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression , 2015, FEBS letters.

[28]  F. Virgilio,et al.  Purinergic signaling in the immune system , 2015, Autonomic Neuroscience.

[29]  C. Clish,et al.  Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α , 2015, Nature Medicine.

[30]  F. Koch-Nolte,et al.  P2X7 on Mouse T Cells: One Channel, Many Functions , 2015, Front. Immunol..

[31]  F. Di Virgilio,et al.  Accelerated tumor progression in mice lacking the ATP receptor P2X7. , 2015, Cancer research.

[32]  C. Takiya,et al.  The P2X7 Receptor Contributes to the Development of the Exacerbated Inflammatory Response Associated with Sepsis , 2015, Journal of Innate Immunity.

[33]  T. Egan,et al.  Quantifying Ca2+ Current and Permeability in ATP-gated P2X7 Receptors* , 2015, The Journal of Biological Chemistry.

[34]  Sarah L. Doyle,et al.  Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives , 2015, Journal of inflammation research.

[35]  M. Toribio,et al.  Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression. , 2014, Journal of autoimmunity.

[36]  B. Brannetti,et al.  ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism. , 2014, Immunity.

[37]  F. Di Virgilio,et al.  Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma , 2014, PloS one.

[38]  A. Viola,et al.  Adenosine triphosphate acts as a paracrine signaling molecule to reduce the motility of T cells , 2014, The EMBO journal.

[39]  F. Sutterwala,et al.  Mechanism of NLRP3 inflammasome activation , 2014, Annals of the New York Academy of Sciences.

[40]  Michael J. Zilliox,et al.  Identification of novel markers for mouse CD4+ T follicular helper cells , 2013, European journal of immunology.

[41]  N. Yang,et al.  P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway. , 2013, Arthritis and rheumatism.

[42]  M. Saleh,et al.  Functions of NOD-Like Receptors in Human Diseases , 2013, Front. Immunol..

[43]  E. Vizi,et al.  CD39 and CD73 in immunity and inflammation. , 2013, Trends in molecular medicine.

[44]  L. Cosmi,et al.  IL-1 and T Helper Immune Responses , 2013, Front. Immunol..

[45]  L. A. Alves,et al.  Is pannexin the pore associated with the P2X7 receptor? , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[46]  J. Schenkel,et al.  The integration of T cell migration, differentiation and function , 2013, Nature Reviews Immunology.

[47]  L. Ferris,et al.  Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of Psoriasis , 2013, The Journal of Immunology.

[48]  Thomas Gebhardt,et al.  Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.

[49]  M. Waxham,et al.  Calcium-calmodulin-dependent protein kinase II isoforms differentially impact the dynamics and structure of the actin cytoskeleton. , 2013, Biochemistry.

[50]  S. Ward,et al.  Mitochondrial Superoxide Generation Enhances P2X7R-Mediated Loss of Cell Surface CD62L on Naive Human CD4+ T Lymphocytes , 2013, The Journal of Immunology.

[51]  C. Ricordi,et al.  Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7 , 2013, Circulation.

[52]  C. Ricordi,et al.  Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection , 2013, Diabetes.

[53]  F. Regateiro,et al.  CD73 and adenosine generation in the creation of regulatory microenvironments , 2013, Clinical and experimental immunology.

[54]  M. Sitkovsky,et al.  Purinergic signaling during inflammation. , 2012, The New England journal of medicine.

[55]  P. Dagnelie,et al.  The P2X7 loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levels , 2012, BMC Immunology.

[56]  M. Seman,et al.  Extracellular NAD(+): a danger signal hindering regulatory T cells. , 2012, Microbes and infection.

[57]  G. Burnstock,et al.  P2X7 receptors: channels, pores and more. , 2012, CNS & neurological disorders drug targets.

[58]  D. Górecki,et al.  Splice variants of the P2X7 receptor reveal differential agonist dependence and functional coupling with pannexin-1 , 2012, Journal of Cell Science.

[59]  F. Di Virgilio,et al.  Extracellular ATP Exerts Opposite Effects on Activated and Regulatory CD4+ T Cells via Purinergic P2 Receptor Activation , 2012, The Journal of Immunology.

[60]  A. Nicke,et al.  Alternative Splicing of the N-Terminal Cytosolic and Transmembrane Domains of P2X7 Controls Gating of the Ion Channel by ADP-Ribosylation , 2012, PloS one.

[61]  M. Rossol,et al.  Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors , 2012, Nature Communications.

[62]  V. Kuchroo,et al.  Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. , 2011, Seminars in immunology.

[63]  Lin-Hua Jiang,et al.  Pharmacological properties of the rhesus macaque monkey P2X7 receptor , 2011, British journal of pharmacology.

[64]  M. Baumann,et al.  Serum Amyloid A Activates the NLRP3 Inflammasome via P2X7 Receptor and a Cathepsin B-Sensitive Pathway , 2011, The Journal of Immunology.

[65]  W. Junger,et al.  Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.

[66]  Fabio Grassi,et al.  ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X Receptors , 2011, Science Signaling.

[67]  Dalya R. Soond,et al.  The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells , 2011, PloS one.

[68]  Christopher A Hunter,et al.  Dendritic Cells Distinguish Individual Chemokine Signals through CCR7 and CXCR4 , 2011, The Journal of Immunology.

[69]  M. Idzko,et al.  Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R , 2010, Nature Medicine.

[70]  M. Seman,et al.  Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2–P2X7 pathway , 2010, The Journal of experimental medicine.

[71]  P. Insel,et al.  Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. , 2010, Blood.

[72]  F. Di Virgilio,et al.  Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  F. Koch-Nolte,et al.  A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes. , 2010, Journal of autoimmunity.

[74]  E. Fonfria,et al.  Cloning and pharmacological characterization of the dog P2X7 receptor , 2009, British journal of pharmacology.

[75]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[76]  Michael R. Elliott,et al.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.

[77]  A. Nicke,et al.  A Functional P2X7 Splice Variant with an Alternative Transmembrane Domain 1 Escapes Gene Inactivation in P2X7 Knock-out Mice* , 2009, The Journal of Biological Chemistry.

[78]  P. Insel,et al.  Autocrine regulation of T‐cell activation by ATP release and P2X7 receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  F. Di Virgilio,et al.  Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression1 , 2009, The Journal of Immunology.

[80]  K. Horiuchi,et al.  ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. , 2009, Molecular biology of the cell.

[81]  M. Seman,et al.  NAD+ and ATP Released from Injured Cells Induce P2X7-Dependent Shedding of CD62L and Externalization of Phosphatidylserine by Murine T Cells1 , 2009, The Journal of Immunology.

[82]  Lin-Hua Jiang.  Inhibition of P2X7 receptors by divalent cations: old action and new insight , 2009, European Biophysics Journal.

[83]  Masahiro Yamamoto,et al.  ATP drives lamina propria TH17 cell differentiation , 2008, Nature.

[84]  M. Gavala,et al.  The nucleotide receptor P2RX7 mediates ATP‐induced CREB activation in human and murine monocytic cells , 2008, Journal of leukocyte biology.

[85]  J. Buer,et al.  Purinergic Control of T Cell Activation by ATP Released Through Pannexin-1 Hemichannels , 2008, Science Signaling.

[86]  H. Mittrücker,et al.  High Sensitivity of Intestinal CD8+ T Cells to Nucleotides Indicates P2X7 as a Regulator for Intestinal T Cell Responses1 , 2008, The Journal of Immunology.

[87]  E. Bongarzone,et al.  P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis , 2008, Journal of Neuroinflammation.

[88]  F. Di Virgilio,et al.  Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase , 2008, PloS one.

[89]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[90]  G. Yegutkin.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. , 2008, Biochimica et biophysica acta.

[91]  M. Seman,et al.  ADP‐ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[92]  C. Higgins,et al.  Sequential Shrinkage and Swelling Underlie P2X7-Stimulated Lymphocyte Phosphatidylserine Exposure and Death1 , 2008, The Journal of Immunology.

[93]  P. Rossini,et al.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.

[94]  M. Seman,et al.  NAD+ Released during Inflammation Participates in T Cell Homeostasis by Inducing ART2-Mediated Death of Naive T Cells In Vivo1 , 2007, The Journal of Immunology.

[95]  V. Kuchroo,et al.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.

[96]  M. Idzko,et al.  Chemotactic activity of extracellular nucleotideson human immune cells. , 2007, Purinergic Signalling.

[97]  D. Spray,et al.  Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex , 2007, FEBS letters.

[98]  M. Seman,et al.  Extracellular NAD and ATP: Partners in immune cell modulation , 2007, Purinergic Signalling.

[99]  R. Sluyter,et al.  Rottlerin inhibits P2X7 receptor‐stimulated phospholipase D activity in chronic lymphocytic leukaemia B‐lymphocytes , 2007, Immunology and cell biology.

[100]  Hon Cheung Lee.  Structure and Enzymatic Functions of Human CD38 , 2006, Molecular medicine.

[101]  A. Surprenant,et al.  Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor , 2006, The EMBO journal.

[102]  G. Dennert,et al.  P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes. , 2006, Cellular immunology.

[103]  A. Ikari,et al.  P2X7 Receptor-Dependent Cell Death Is Modulated during Murine T Cell Maturation and Mediated by Dual Signaling Pathways1 , 2006, The Journal of Immunology.

[104]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[105]  J. Sévigny,et al.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.

[106]  A. Gomez-Muñoz,et al.  Coupling of two pools of P2X7 receptors to distinct intracellular signaling pathways in rat submandibular glands⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary figure. Published, JLR Papers in Press, January 16, 2006. , 2006, Journal of Lipid Research.

[107]  G. Dennert,et al.  High Sensitivity of CD4+CD25+ Regulatory T Cells to Extracellular Metabolites Nicotinamide Adenine Dinucleotide and ATP: A Role for P2X7 Receptors1 , 2005, The Journal of Immunology.

[108]  J. Kanellopoulos,et al.  A Role for Mitogen-activated Protein KinaseErk1/2 Activation and Non-selective Pore Formation in P2X7 Receptor-mediated Thymocyte Death* , 2005, Journal of Biological Chemistry.

[109]  F. Di Virgilio,et al.  P2X7 receptor: Death or life? , 2005, Purinergic Signalling.

[110]  S. Greenfeder,et al.  Identification and characterization of splice variants of the human P2X7 ATP channel. , 2005, Biochemical and biophysical research communications.

[111]  S. Robson,et al.  Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. , 2005, Seminars in thrombosis and hemostasis.

[112]  N. Oppenheimer,et al.  CD38 Controls ADP-Ribosyltransferase-2-Catalyzed ADP-Ribosylation of T Cell Surface Proteins1 , 2005, The Journal of Immunology.

[113]  J. Cebon,et al.  Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. , 2005, Blood.

[114]  E. Leiter,et al.  P2X7 Receptor-Dependent and -Independent T Cell Death Is Induced by Nicotinamide Adenine Dinucleotide1 , 2005, The Journal of Immunology.

[115]  L. A. Alves,et al.  Are second messengers crucial for opening the pore associated with P2X7 receptor? , 2005, American journal of physiology. Cell physiology.

[116]  A. Ikari,et al.  Involvement of Chloride in Apoptotic Cell Death Induced by Activation of ATP-sensitive P2X7 Purinoceptor* , 2005, Journal of Biological Chemistry.

[117]  P. Sopp,et al.  The role of dendritic cells in shaping the immune response , 2004, Animal Health Research Reviews.

[118]  F. Di Virgilio,et al.  The Antibiotic Polymyxin B Modulates P2X7 Receptor Function1 , 2004, The Journal of Immunology.

[119]  G. Dahl,et al.  Pannexin membrane channels are mechanosensitive conduits for ATP , 2004, FEBS letters.

[120]  J. Kanellopoulos,et al.  The Pro-451 to Leu Polymorphism within the C-terminal Tail of P2X7 Receptor Impairs Cell Death but Not Phospholipase D Activation in Murine Thymocytes* , 2004, Journal of Biological Chemistry.

[121]  J. Wiley,et al.  Glu496 to Ala Polymorphism in the P2X7 Receptor Impairs ATP-Induced IL-1β Release from Human Monocytes1 , 2004, The Journal of Immunology.

[122]  W. Britton,et al.  A Loss-of-Function Polymorphism in the Human P2X7 Receptor Abolishes ATP-Mediated Killing of Mycobacteria 1 , 2003, The Journal of Immunology.

[123]  M. Seman,et al.  NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. , 2003, Immunity.

[124]  I. Novak,et al.  P2X7 receptor activates extracellular signal-regulated kinases ERK1 and ERK2 independently of Ca2+ influx. , 2003, The Biochemical journal.

[125]  G. Dubyak,et al.  Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. , 2003, American journal of physiology. Cell physiology.

[126]  F. Di Virgilio,et al.  Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. , 2003, Molecular biology of the cell.

[127]  S. Petrou,et al.  P2X7 Receptor Cell Surface Expression and Cytolytic Pore Formation Are Regulated by a Distal C-terminal Region* , 2003, The Journal of Biological Chemistry.

[128]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[129]  F. Di Virgilio,et al.  Alerting and tuning the immune response by extracellular nucleotides , 2003, Journal of leukocyte biology.

[130]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[131]  M. Seman,et al.  Cutting Edge: A Natural P451L Mutation in the Cytoplasmic Domain Impairs the Function of the Mouse P2X7 Receptor1 , 2002, The Journal of Immunology.

[132]  M. Goldman,et al.  Extracellular adenine nucleotides modulate cytokine production by human monocyte‐derived dendritic cells: dual effect on IL‐12 and stimulation of IL‐10 , 2002, European journal of immunology.

[133]  C. Gabel,et al.  Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response , 2002, The Journal of Immunology.

[134]  Akira Takashima,et al.  CD39 is the dominant Langerhans cell–associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness , 2002, Nature Medicine.

[135]  J. Wiley,et al.  A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study , 2002, The Lancet.

[136]  F. Di Virgilio,et al.  Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. , 2002, Blood.

[137]  Denise Feighan,et al.  P2X7-Like Receptor Activation in Astrocytes Increases Chemokine Monocyte Chemoattractant Protein-1 Expression via Mitogen-Activated Protein Kinase , 2001, The Journal of Neuroscience.

[138]  F. Di Virgilio,et al.  Extracellular ATP Induces a Distorted Maturation of Dendritic Cells and Inhibits Their Capacity to Initiate Th1 Responses1 , 2001, The Journal of Immunology.

[139]  Beverly H. Koller,et al.  Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.

[140]  E. Zocchi,et al.  Connexin 43 hemichannels mediate Ca2+‐regulated transmembrane NAD+ fluxes in intact cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[141]  F. Di Virgilio,et al.  The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[142]  F. Di Virgilio,et al.  Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. , 1999, Journal of immunology.

[143]  I. Chessell,et al.  Ionic effects on human recombinant P2X7 receptor function , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[144]  E. Barnard,et al.  Cloning and functional characterisation of the mouse P2X7 receptor , 1998, FEBS letters.

[145]  F. Powrie,et al.  CD38+ CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activities in vitro , 1998, European journal of immunology.

[146]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[147]  D. Ferrari,et al.  Cytolytic P2X purinoceptors , 1998, Cell Death and Differentiation.

[148]  Caterina Virginio,et al.  Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor , 1997, Neuropharmacology.

[149]  Caterina Virginio,et al.  The Permeabilizing ATP Receptor, P2X7 , 1997, The Journal of Biological Chemistry.

[150]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[151]  F. Koch-Nolte,et al.  Premature stop codons inactivate the RT6 genes of the human and chimpanzee species. , 1994, Journal of molecular biology.

[152]  K. Ley,et al.  Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. , 1994, Immunity.

[153]  T. Steinberg,et al.  Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. , 1991, The Journal of biological chemistry.

[154]  Rottoli,et al.  P 2 X 7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus , 2019 .

[155]  M. Bours,et al.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.

[156]  H. Smits,et al.  Dendritic cell-mediated T cell polarization , 2004, Springer Seminars in Immunopathology.

[157]  G. Burnstock,et al.  Cellular distribution and functions of P2 receptor subtypes in different systems. , 2004, International review of cytology.

[158]  A. Rudensky,et al.  Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells , 2003 .